Market Research Logo

Immunoglobulin E (IgE) Allergy Blood Tests - Medical Devices Pipeline Assessment, 2018

Immunoglobulin E (IgE) Allergy Blood Tests - Medical Devices Pipeline Assessment, 2018

Summary

GlobalData's Medical Devices sector report, “Immunoglobulin E (IgE) Allergy Blood Tests - Medical Devices Pipeline Assessment, 2018 provides an overview of Immunoglobulin E (IgE) Allergy Blood Tests currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Immunoglobulin E (IgE) Allergy Blood Tests pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

  • Extensive coverage of the Immunoglobulin E (IgE) Allergy Blood Tests under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Immunoglobulin E (IgE) Allergy Blood Tests and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry.
Reasons to buy

The report enables you to -
  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Immunoglobulin E (IgE) Allergy Blood Tests under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product’s current stage of development, territory and estimated launch date.


1 Table of Contents
1.1 List of Tables
1.2 List of Figures
2 Introduction
2.1 Immunoglobulin E (IgE) Allergy Blood Tests Overview
3 Products under Development
3.1 Immunoglobulin E (IgE) Allergy Blood Tests - Pipeline Products by Stage of Development
3.2 Immunoglobulin E (IgE) Allergy Blood Tests - Pipeline Products by Segment
3.3 Immunoglobulin E (IgE) Allergy Blood Tests - Pipeline Products by Territory
3.4 Immunoglobulin E (IgE) Allergy Blood Tests - Pipeline Products by Regulatory Path
3.5 Immunoglobulin E (IgE) Allergy Blood Tests - Pipeline Products by Estimated Approval Date
4 Immunoglobulin E (IgE) Allergy Blood Tests - Pipeline Products under Development by Companies
4.1 Immunoglobulin E (IgE) Allergy Blood Tests Companies - Pipeline Products by Stage of Development
4.2 Immunoglobulin E (IgE) Allergy Blood Tests - Pipeline Products by Stage of Development
5 Immunoglobulin E (IgE) Allergy Blood Tests Companies and Product Overview
5.1 Abionic SA Company Overview
5.2 Amerimmune Company Overview
5.3 AXO Science SAS Company Overview
5.4 Biovator AB (Inactive) Company Overview
5.5 Children's Hospital Boston Company Overview
5.6 China Medical Technologies Inc (Inactive) Company Overview
5.7 Cytognos, SL Company Overview
5.8 EUROIMMUN US LLC Company Overview
5.9 Ferrer inCode SL Company Overview
5.10 HOB Biotech Group Suzhou Co Ltd Company Overview
5.11 Hycor Biomedical Inc Company Overview
5.12 Institut fur Produktqualitat GmbH Company Overview
5.13 IRCCS San Raffaele Hospital Company Overview
5.14 Medical Research Council Company Overview
5.15 Stanford University Company Overview
5.16 Thermo Fisher Scientific Inc Company Overview
5.17 University of Connecticut Health Center Company Overview
5.18 University of Nottingham Company Overview
5.19 University of Queensland Company Overview
5.20 VEGA Ltd Company Overview
6 Immunoglobulin E (IgE) Allergy Blood Tests- Recent Developments
6.1 Jul 02, 2018: Arrayit Completes Allergy Testing Pilot Program for One of the Nation’s Largest Retail Chains
6.2 Jun 12, 2018: Change at the top of the Segment Advanced Therapies at Siemens Healthineers
6.3 May 10, 2018: Researchers develop a new test to safely and accurately diagnose peanut allergies
6.4 May 08, 2018: Omega Diagnostics Group Announced CE-Mark for Allersys
6.5 May 03, 2018: Scientists develop a new test to safely and accurately diagnose peanut allergies
6.6 May 03, 2018: Siemens Healthineers fully on track to meet the targets
6.7 Apr 25, 2018: Thermo Fisher Scientific Reports First Quarter 2018 Results
6.8 Apr 10, 2018: Theradiag reports its 2017 annual results and sales for first quarter 2018
6.9 Mar 16, 2018: Thermo Fisher Scientific Announces Plans To Build State-Of-The-Art Pharma Services Facility In Rheinfelden
6.10 Feb 20, 2018: Theradiag Announces 2017 Annual Sales and Cash Flow at End 2017
6.11 Feb 15, 2018: NuVision follows its vision with £500,000 investment
6.12 Jan 31, 2018: Thermo Fisher Scientific Reports Fourth Quarter and Full Year 2017 Results
6.13 Jan 31, 2018: Thermo Fisher Scientific Uses Tax Reform Benefit to Make Additional Investments in Colleagues, Customers and Communities
6.14 Jan 30, 2018: Siemens Healthineers Names Deepak Nath Head of Laboratory Diagnostics
6.15 Dec 29, 2017: Thermo Fisher Scientific Completes Acquisition of Phenom-World
6.16 Dec 21, 2017: Omega Diagnostics Group Receives CE-Mark for Allersys
6.17 Dec 19, 2017: THERADIAG provides an update on Prestizia and its partnership with HOB Biotech
6.18 Dec 06, 2017: Abionic Announces Appointment of Leading Diagnostics Industry Experts to Board of Directors
6.19 Nov 29, 2017: Siemens plans to list Siemens Healthineers on Frankfurt Stock Exchange
6.20 Oct 26, 2017: Theradiag: Revenues at the end of September 30, 2017
6.21 Oct 25, 2017: Thermo Fisher Scientific Reports Third Quarter 2017 Results
6.22 Oct 20, 2017: Abionic Announces FDA Registration for World’s Most Rapid Allergy Test and abioSCOPE Diagnostic Testing Platform
6.23 Sep 19, 2017: Theradiag: Results and activity for the first half of 2017 Continued improvement in results
6.24 Jul 26, 2017: Thermo Fisher Scientific Reports Second Quarter 2017 Results
6.25 Jul 25, 2017: Theradiag: Further Strong Sales Growth in the First Half of 2017: +9%
6.26 Jul 12, 2017: Premaitha Health: Investment Agreement Extension with Thermo Fisher Scientific
7 Appendix
7.1 Methodology
7.2 About GlobalData
7.3 Contact Us
7.4 Disclaimer
1.1 List of Tables
Table 1: Immunoglobulin E (IgE) Allergy Blood Tests - Pipeline Products by Stage of Development
Table 2: Immunoglobulin E (IgE) Allergy Blood Tests - Pipeline Products by Segment
Table 3: Immunoglobulin E (IgE) Allergy Blood Tests - Pipeline Products by Territory
Table 4: Immunoglobulin E (IgE) Allergy Blood Tests - Pipeline Products by Regulatory Path
Table 5: Immunoglobulin E (IgE) Allergy Blood Tests - Pipeline Products by Estimated Approval Date
Table 6: Immunoglobulin E (IgE) Allergy Blood Tests Companies - Pipeline Products by Stage of Development
Table 7: Immunoglobulin E (IgE) Allergy Blood Tests - Pipeline Products by Stage of Development
Table 8: Abionic SA Pipeline Products & Ongoing Clinical Trials Overview
Table 9: abioKIT-a - 6 Tests In 12 Min - Product Status
Table 10: abioKIT-a - 6 Tests In 12 Min - Product Description
Table 11: IVD CAPSULE Aeroallergens - Product Status
Table 12: IVD CAPSULE Aeroallergens - Product Description
Table 13: Amerimmune Pipeline Products & Ongoing Clinical Trials Overview
Table 14: Basophile Panel - Product Status
Table 15: Basophile Panel - Product Description
Table 16: CD69 and IgE Receptor Expression Assay - Product Status
Table 17: CD69 and IgE Receptor Expression Assay - Product Description
Table 18: AXO Science SAS Pipeline Products & Ongoing Clinical Trials Overview
Table 19: Diagnostic Test - Allergy - Product Status
Table 20: Diagnostic Test - Allergy - Product Description
Table 21: Biovator AB (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
Table 22: Cytokine Profile Assay - Product Status
Table 23: Cytokine Profile Assay - Product Description
Table 24: Children's Hospital Boston Pipeline Products & Ongoing Clinical Trials Overview
Table 25: Biomarker Assay - Allergy - Product Status
Table 26: Biomarker Assay - Allergy - Product Description
Table 27: China Medical Technologies Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
Table 28: Diagnostic Assay - Total IgE - Product Status
Table 29: Diagnostic Assay - Total IgE - Product Description
Table 30: Cytognos, SL Pipeline Products & Ongoing Clinical Trials Overview
Table 31: Diagnosis Flow Cytometry Kit - Type 1 Hypersensitivity - Product Status
Table 32: Diagnosis Flow Cytometry Kit - Type 1 Hypersensitivity - Product Description
Table 33: EUROIMMUN US LLC Pipeline Products & Ongoing Clinical Trials Overview
Table 34: IgE Allergy Test - DP 3134-1601-1 E - Product Status
Table 35: IgE Allergy Test - DP 3134-1601-1 E - Product Description
Table 36: IgE Allergy Test - DP 3134-1601-2 E - Product Status
Table 37: IgE Allergy Test - DP 3134-1601-2 E - Product Description
Table 38: Ferrer inCode SL Pipeline Products & Ongoing Clinical Trials Overview
Table 39: DAP - Product Status
Table 40: DAP - Product Description
Table 41: HOB Biotech Group Suzhou Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 42: HOB Biotech Diagnostic Assay - Allergy - Product Status
Table 43: HOB Biotech Diagnostic Assay - Allergy - Product Description
Table 44: Hycor Biomedical Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 45: HYTEC 288 PLUS - Eosinophil Cationic Protein Test - Product Status
Table 46: HYTEC 288 PLUS - Eosinophil Cationic Protein Test - Product Description
Table 47: HYTEC 288 PLUS - Tryptase Test - Product Status
Table 48: HYTEC 288 PLUS - Tryptase Test - Product Description
Table 49: Institut fur Produktqualitat GmbH Pipeline Products & Ongoing Clinical Trials Overview
Table 50: Diagnostic Test - Allergy - Product Status
Table 51: Diagnostic Test - Allergy - Product Description
Table 52: IRCCS San Raffaele Hospital Pipeline Products & Ongoing Clinical Trials Overview
Table 53: Diagnostic Test - Allergic Asthma - Product Status
Table 54: Diagnostic Test - Allergic Asthma - Product Description
Table 55: Medical Research Council Pipeline Products & Ongoing Clinical Trials Overview
Table 56: Mast Activation Test - Product Status
Table 57: Mast Activation Test - Product Description
Table 58: Stanford University Pipeline Products & Ongoing Clinical Trials Overview
Table 59: Basophil Activation Test - Product Status
Table 60: Basophil Activation Test - Product Description
Table 61: Thermo Fisher Scientific Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 62: Diagnostic Test - Allergy - Product Status
Table 63: Diagnostic Test - Allergy - Product Description
Table 64: University of Connecticut Health Center Pipeline Products & Ongoing Clinical Trials Overview
Table 65: Ultrasensitive Peanut Allergy Test - Product Status
Table 66: Ultrasensitive Peanut Allergy Test - Product Description
Table 67: University of Nottingham Pipeline Products & Ongoing Clinical Trials Overview
Table 68: Allergy Test - Product Status
Table 69: Allergy Test - Product Description
Table 70: University of Queensland Pipeline Products & Ongoing Clinical Trials Overview
Table 71: Diagnostic Assay - Allergy - Product Status
Table 72: Diagnostic Assay - Allergy - Product Description
Table 73: VEGA Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 74: Microarray Based Allergen Diagnostic Kit - Product Status
Table 75: Microarray Based Allergen Diagnostic Kit - Product Description
Table 76: Glossary
1.2 List of Figures
Figure 1: Immunoglobulin E (IgE) Allergy Blood Tests - Pipeline Products by Stage of Development
Figure 2: Immunoglobulin E (IgE) Allergy Blood Tests - Pipeline Products by Segment
Figure 3: Immunoglobulin E (IgE) Allergy Blood Tests - Pipeline Products by Territory
Figure 4: Immunoglobulin E (IgE) Allergy Blood Tests - Pipeline Products by Regulatory Path
Figure 5: Immunoglobulin E (IgE) Allergy Blood Tests - Pipeline Products by Estimated Approval Date

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report